Clinical Trial Update: Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating computerized cognition testing in participants with mild Alzheimer's disease treated with donepezil (MK-0000-318).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-08-01